## TEAM: Atlassian Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 2.5% below STRENGTH zone (4.0-10.0%); PEG 1.67 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($150.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.53M) |
| Sells | 130 ($28.80M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.0% (+6.0%)
- Blackrock Inc.: 6.3% (-1.4%)
- BAILLIE GIFFORD & CO: 4.8% (-4.8%)
- JPMORGAN CHASE & CO: 2.9% (+22.6%)
- State Street Corpora: 2.3% (+1.9%)

### Key Risks

1. Heavy insider selling: $29M sold (130 transactions in 90 days).
2. Long-term trend broken: trading 13.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.67 elevated, pricing in significant growth expectations. Insider selling cluster ($28.8M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $42.4B |
| Beta | 0.90 |
| 52W Range | $139.70 - $326.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.67 |
| Forward P/E | 28.6 |
| Current P/E | 33.1 |
| YoY Growth | 15.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 4.0% to 2.5% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram positive (0.76), confirming momentum. RSI neutral at 55. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: -MUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.49% (CS: 73) | Neutral |
| RSI_14 | 55.0 | Neutral |
| MACD Histogram | 0.76 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 0.866x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $161.07
- **Stop Loss:** $150.29 (6.7% risk)
- **Target:** $171.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $17,878.77
- **Portfolio %:** 17.88%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-29 (Est: $1.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.84 | $1.04 | +24.1% |
| 2025Q2 | $0.85 | $0.98 | +14.6% |
| 2025Q1 | $0.93 | $0.97 | +4.8% |
| 2024Q4 | $0.76 | $0.96 | +27.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*